ADAM12 and pancreatic ductal adenocarcinoma: It was found by Yu et al. (Yu et al., 2012) that CAFs derived from pancreatic ductal adenocarcinoma displayed lower methylation levels and overexpression of ADAM metallopeptidase domain 12 compared to normal fibroblasts.